Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Sculptor Capital LP

Q1 2025 · 13F-HR/A

Sculptor Capital LPholdings as filed

Filed 2026-02-26 · accession 0000905148-26-001050

$28.8M
Reported value
7
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G0509J107AACBUARTIUS II ACQUISITION INC$20.0M69.5%1,980,000CommonSHARED
98421MAE6XRX 3.75 03/15/30XEROX HOLDINGS CORP$4.4M15.2%7,500,000CommonSHARED
92333F101VGVENTURE GLOBAL INC$2.2M7.56%211,350CommonSHARED
48251W500KKR 6.25 03/01/28 DKKR & CO INC$1.9M6.50%37,888CommonSHARED
29103K118FLDDWFOLD HLDGS INC$250,2690.87%345,200CommonSOLE
092915115BZAIWBLAIZE HLDGS INC$66,0630.23%350,000CommonSHARED
738920115ASBPWASPIRE BIOPHARMA HLDGS INC$36,5000.13%2,405,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.